BARNES-JEWISH HOSPITAL
1. Target Overview & Investment Thesis
BARNES-JEWISH HOSPITAL is a 1259-bed large academic medical center in ST. LOUIS CITY, MO with $2.42B in net patient revenue and a -2.0% operating margin. The hospital serves a payer mix of 24.5% Medicare, 10.3% Medicaid, and 65.2% commercial.
Thesis: Undervalued. Our ML models identify $178.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -2.0% to 5.4% (+736bps).
| Net Revenue HCRIS | $2.42B |
| Current EBITDA COMPUTED | $-47.3M |
| Operating Margin COMPUTED | -2.0% |
| Occupancy HCRIS | 80.5% |
| Revenue / Bed COMPUTED | $1.9M |
| Net-to-Gross HCRIS | 31.0% |
| Distress Probability ML | 45.4% |
2. Market Context & Competitive Position
MO has 138 Medicare-certified hospitals with a median operating margin of -6.2%. The target's margin of -2.0% places it above the state median. Among 155 size-comparable peers (630-2518 beds), the median margin is -5.0%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (630-2518), prioritizing same-state peers. 155 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| BARNES-JEWISH HOSPITAL (Target) | MO | 1259 | $2.42B | -2.0% |
| ST. LUKES HOSPITAL | PA | 633 | $8.94B | 87.9% |
| NYU LANGONE HOSPITALS | NY | 1618 | $7.24B | -7.8% |
| STANFORD HEALTH CARE | CA | 657 | $6.76B | 3.7% |
| CLEVELAND CLINIC HOSPITAL | OH | 1326 | $6.38B | -17.7% |
| VANDERBILT UNIVERSITY MEDICAL | TN | 1084 | $5.44B | -15.9% |
| UCSF MEDICAL CENTER | CA | 834 | $5.44B | -5.4% |
| UT MD ANDERSON CANCER CENTER | TX | 721 | $4.90B | -0.8% |
| UNIV OF MI HOSPITALS & HLTH CT | MI | 951 | $4.62B | -1.4% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $178.0M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $50.8M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $48.4M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $47.9M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $29.4M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $1.5M | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-47.3M |
| + RCM Uplift | +$178.0M |
| Pro Forma EBITDA | $130.7M |
| Current Margin | -2.0% |
| Pro Forma Margin | 5.4% |
| WC Released (1x) | $92.8M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-72.8M | $1.47B | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-72.8M | $1.59B | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-65.5M | $2.15B | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-65.5M | $2.33B | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-80.1M | $601.5M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-80.1M | $635.6M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 155 hospitals with 630-2518 beds
- Same-state prioritization (n=4)
- Comp margins: P25=-16.0% / P50=-5.0% / P75=4.1%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.